|
ZNF512 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.731400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.596200E-01 |
| Normal-vs-Stage2 |
7.313200E-01 |
| Normal-vs-Stage3 |
1.683570E-01 |
| Normal-vs-Stage4 |
1.708260E-02 |
| Stage1-vs-Stage2 |
7.778800E-01 |
| Stage1-vs-Stage3 |
5.440000E-02 |
| Stage1-vs-Stage4 |
2.080500E-03 |
| Stage2-vs-Stage3 |
1.317190E-01 |
| Stage2-vs-Stage4 |
3.731500E-02 |
| Stage3-vs-Stage4 |
3.307800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.864800E-01 |
| Normal-vs-AfricanAmerican |
1.507600E-01 |
| Normal-vs-Asian |
6.553900E-02 |
| Caucasian-vs-AfricanAmerican |
2.670200E-01 |
| Caucasian-vs-Asian |
6.938200E-02 |
| AfricanAmerican-vs-Asian |
3.226500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.556400E-01 |
| Normal-vs-Female |
4.550200E-01 |
| Male-vs-Female |
7.394400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.900000E-01 |
| Normal-vs-Age(41-60Yrs) |
8.219000E-01 |
| Normal-vs-Age(61-80Yrs) |
4.413400E-01 |
| Normal-vs-Age(81-100Yrs) |
1.828960E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.771600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.717200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.110200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.018800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.551600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.072000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.878190E-01 |
| Normal-vs-Grade 2 |
5.194200E-01 |
| Normal-vs-Grade 3 |
3.625600E-01 |
| Normal-vs-Grade 4 |
6.756900E-04 |
| Grade 1-vs-Grade 2 |
3.839000E-01 |
| Grade 1-vs-Grade 3 |
8.582300E-02 |
| Grade 1-vs-Grade 4 |
2.081700E-03 |
| Grade 2-vs-Grade 3 |
4.673900E-02 |
| Grade 2-vs-Grade 4 |
3.68360000000401E-05 |
| Grade 3-vs-Grade 4 |
2.503700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.124390E-01 |
| Normal-vs-ccB subtype |
7.355900E-02 |
| ccA subtype-vs-ccB subtype |
3.95490000000276E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.408000E-01 |
| Normal-vs-N1 |
5.911800E-01 |
| N0-vs-N1 |
7.939400E-01 |
|
|
